ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Teams With Oblique On Antibody Di
ScripElevateBio, LLC launched in 2019 as a cell and gene therapy R&D and manufacturing hub for its subsidiary companies and partners, and with demand for its know-how growing, the firm has raised $410m in